Literature DB >> 28068557

Cordycepin inhibits migration of human glioblastoma cells by affecting lysosomal degradation and protein phosphatase activation.

Dueng-Yuan Hueng1, Ching-Hsuan Hsieh2, Yu-Chen Cheng2, Wen-Chiuan Tsai3, Ying Chen4.   

Abstract

Cordycepin, a nucleoside-derivative-isolated form Cordyceps militaris, has been reported to suppress tumor cell proliferation and cause apoptosis. This study investigates the effect of cordycepin on the migration of human glioblastoma cells. Cordycepin suppressed the migration of the human glioblastoma cell lines U87MG and LN229 in transwell and wound healing assays. Cordycepin decreased protein expression of integrin α1, focal adhesion kinase (FAK), p-FAK, paxillin and p-paxillin. The lysosomal inhibitor NH4Cl blocked the ability of cordycepin to inhibit focal adhesion protein expression and glioma cell migration. In addition, the protein phosphatase inhibitors calyculin A and okadaic acid blocked the cordycepin-mediated reduction in p-Akt, p-FAK and migration. Hematoxylin and eosin staining of mouse xenografts demonstrated that cordycepin reduced brain tumor size in vivo. In conclusion, cordycepin inhibited migration of human glioblastoma cells by affecting lysosomal degradation and protein phosphatase activation. This pathway may be a useful target for clinical therapy in the future.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28068557     DOI: 10.1016/j.jnutbio.2016.12.008

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  7 in total

1.  Cordycepin, a Characteristic Bioactive Constituent in Cordyceps militaris, Ameliorates Hyperuricemia through URAT1 in Hyperuricemic Mice.

Authors:  Tianqiao Yong; Shaodan Chen; Yizhen Xie; Diling Chen; Jiyan Su; Ou Shuai; Chunwei Jiao; Dan Zuo
Journal:  Front Microbiol       Date:  2018-01-25       Impact factor: 5.640

2.  Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways.

Authors:  Ya-Jun Zhang; Zhi-Gang Xu; Shi-Qiang Li; Liu-Jun He; Yan Tang; Zhong-Zhu Chen; Dong-Lin Yang
Journal:  Cancer Cell Int       Date:  2018-06-28       Impact factor: 5.722

3.  miR-185 inhibits prostate cancer angiogenesis induced by the nodal/ALK4 pathway.

Authors:  Youkong Li; Wen Zhong; Min Zhu; Mengbo Li; Zhenwei Yang
Journal:  BMC Urol       Date:  2020-05-04       Impact factor: 2.264

4.  Cordycepin inhibits cell senescence by ameliorating lysosomal dysfunction and inducing autophagy through the AMPK and mTOR-p70S6K pathway.

Authors:  Shi Qi Zuo; Can Li; Yi Lun Liu; Yue Hao Tan; Xing Wan; Tian Xu; Qiang Li; Li Wang; Yong Li Wu; Feng Mei Deng; Bin Tang
Journal:  FEBS Open Bio       Date:  2021-08-27       Impact factor: 2.693

Review 5.  A Systematic Review of the Biological Effects of Cordycepin.

Authors:  Masar Radhi; Sadaf Ashraf; Steven Lawrence; Asta Arendt Tranholm; Peter Arthur David Wellham; Abdul Hafeez; Ammar Sabah Khamis; Robert Thomas; Daniel McWilliams; Cornelia Huiberdina de Moor
Journal:  Molecules       Date:  2021-09-28       Impact factor: 4.411

6.  Role of endolysosomes and pH in the pathogenesis and treatment of glioblastoma.

Authors:  Peter Halcrow; Gaurav Datta; Joyce E Ohm; Mahmoud L Soliman; Xuesong Chen; Jonathan D Geiger
Journal:  Cancer Rep       Date:  2019-05-06

7.  Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris.

Authors:  Ye Jin; Xue Meng; Zhidong Qiu; Yanping Su; Peng Yu; Peng Qu
Journal:  Saudi J Biol Sci       Date:  2018-05-14       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.